ArticleFrontiers in public health2024

Cost-effectiveness analysis of trifluridine/tipiracil combined with bevacizumab vs. monotherapy for third-line treatment of colorectal cancer.

Long-Zhuan Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.